New York metro's largest footprint of F-18 PSMA PET/CT
![F-18 PSMA PET/CT, Lenox Hill Radiology](https://www.radnet.com/lenox-hill-radiology/sites/lenoxhill/files/radnet/field/news/PSMA%20social%20and%20news%20item-ogeneral.jpg)
From Rockland County to Manhattan to Long Island, Lenox Hill Radiology now offers the New York metro's largest footprint of F-18 PSMA PET/CT, an advancement in prostate cancer diagnostic imaging.
PSMA PET/CT is an advanced PSMA-targeted diagnostic imaging modality utilized by urologists and oncologists for prostate cancer diagnosis, staging and treatment monitoring.
PSMA stands for prostate-specific membrane antigen, which is a protein that is highly expressed on the surface of prostate cancer cells. PSMA-targeted PET/CT imaging has greatly improved prostate cancer detection and localization, by offering a highly sensitive and specific exam, which allows for more accurate staging of prostate cancer and earlier detection of metastases. Additionally, PSMA PET/CT imaging can also be used by your doctor to guide biopsy and surgical planning.
Multiple PSMA-targeted therapies are now in development in clinical trials which shows promise in the treatment of prostate cancer. One kind of PSMA-targeted radionuclide therapy (PSMA-TRT), involves the use of radioactive isotopes that are attached to PSMA-targeting agents. These radioactive agents selectively bind to PSMA-expressing cancer cells to deliver a lethal dose of radiation. PSMA-TRT has shown encouraging results in early clinical trials, with high response rates and durable remissions in patients with advanced prostate cancer.
F-18 PET/CT PSMA-targeted imaging and therapy have also been combined with other treatments such as chemotherapy and hormonal therapy, in trials that show promise in improving treatment outcomes for patients with advanced prostate cancer.
Overall, PSMA-targeted therapy has significantly improved prostate cancer detection and treatment, providing new and effective options for patients with this disease.
Following your PSMA PET/CT, your Urologist or Oncologist may recommend new, advanced PSMA-targeted therapy to selectively deliver therapeutic agents to cancer cells while sparing normal tissues. If you would like more information about clinical trials, please visit clinicaltrials.gov and search prostate cancer.
All LHR centers that offer PSMA:
LHR | Columbus Circle Imaging
15 Columbus Circle
9th Floor, LL
New York, NY 10019
LHR | East 66th
400 East 66th Street
New York, NY 10065
LHR | Lynbrook
443 Sunrise Highway
Lynbrook, NY 11563
LHR | Highway Imaging
2095 Flatbush Avenue
Brooklyn, NY 11234
LHR | Kew Gardens
80-02 Kew Gardens Road
Suite L1
Kew Gardens, NY 11415
HVRA | Hudson Valley PET/CT Imaging
111 North Highland Avenue
Nyack, NY 10960
To schedule your patient please call (212) 599-5555 or email LHROMICscheduling@radnet.com